Search
Cooper Companies Inc
COOAdd to Watchlist
60.034USD
+0.084+0.14%
Market hours （ET）Quotes delayed by 15 min
11.71BMarket Cap
29.59P/E TTM
More Details of Cooper Companies Inc Company
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Cooper Companies Inc Info
Ticker SymbolCOO
Company nameCooper Companies Inc
IPO dateJan 21, 1983
CEOWhite (Albert G)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJan 21
Address6101 Bollinger Canyon Road
CitySAN RAMON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94583
Phone19254603600
Websitehttps://www.coopercos.com/
Ticker SymbolCOO
IPO dateJan 21, 1983
CEOWhite (Albert G)
Company Executives of Cooper Companies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Director
Director
550.46K
+0.66%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
43.26K
+9.73%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Chairman of the Board
Independent Chairman of the Board
39.91K
+8.32%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
15.68K
+21.19%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
14.46K
+22.97%
Ms. Cynthia L. (Cindy) Lucchese, CPA
Ms. Cynthia L. (Cindy) Lucchese, CPA
Independent Director
Independent Director
12.77K
+26.02%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Director
Independent Director
11.10K
+29.93%
Mr. Agostino Ricupati
Mr. Agostino Ricupati
Senior Vice President - Finance and Tax, Chief Accounting Officer
Senior Vice President - Finance and Tax, Chief Accounting Officer
7.51K
+13.59%
Mr. Nicholas S. Khadder, J.D.
Mr. Nicholas S. Khadder, J.D.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
2.14K
+76.23%
Mr. Albert G. White, III
Mr. Albert G. White, III
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Director
Director
550.46K
+0.66%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
43.26K
+9.73%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Chairman of the Board
Independent Chairman of the Board
39.91K
+8.32%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
15.68K
+21.19%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
14.46K
+22.97%
Ms. Cynthia L. (Cindy) Lucchese, CPA
Ms. Cynthia L. (Cindy) Lucchese, CPA
Independent Director
Independent Director
12.77K
+26.02%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Toric and multifocal
351.20M
34.29%
Sphere, other
343.90M
33.58%
Office and surgical procedures
202.40M
19.76%
Fertility
126.60M
12.36%
By RegionUSD
Name
Revenue
Proportion
United States
513.90M
50.18%
Europe
326.40M
31.87%
Rest of the World
183.80M
17.95%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Toric and multifocal
351.20M
34.29%
Sphere, other
343.90M
33.58%
Office and surgical procedures
202.40M
19.76%
Fertility
126.60M
12.36%
Shareholding Stats
Updated: 16 hours ago
Updated: 16 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.52%
BlackRock Institutional Trust Company, N.A.
5.33%
Capital World Investors
5.23%
T. Rowe Price Investment Management, Inc.
4.64%
State Street Investment Management (US)
4.51%
Other
73.77%
Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.52%
BlackRock Institutional Trust Company, N.A.
5.33%
Capital World Investors
5.23%
T. Rowe Price Investment Management, Inc.
4.64%
State Street Investment Management (US)
4.51%
Other
73.77%
Shareholder Types
Shareholders
Proportion
Investment Advisor
59.81%
Investment Advisor/Hedge Fund
34.50%
Hedge Fund
6.26%
Research Firm
2.78%
Bank and Trust
1.85%
Pension Fund
1.37%
Family Office
0.91%
Family Office
0.91%
Individual Investor
0.62%
Institutional Shareholding
Updated: Sun, Apr 5
Updated: Sun, Apr 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
1444
209.07M
107.15%
-19.73M
2025Q4
1362
208.96M
111.56%
-3.88K
2025Q3
1410
208.99M
111.74%
+4.12M
2025Q2
1399
205.52M
107.52%
+1.81M
2025Q1
1380
203.24M
103.36%
-3.45M
2024Q4
1357
199.65M
102.09%
+3.47M
2024Q3
1324
195.11M
102.83%
-1.38M
2024Q2
1308
196.62M
100.46%
+4.01M
2024Q1
1307
191.91M
103.85%
-14.49M
2023Q4
1291
198.78M
104.05%
+1.21M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
10.41M
5.33%
+569.80K
+5.79%
Dec 31, 2025
Capital World Investors
10.21M
5.23%
-343.39K
-3.25%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
9.05M
4.64%
-779.49K
-7.93%
Dec 31, 2025
State Street Investment Management (US)
8.79M
4.51%
+207.19K
+2.41%
Dec 31, 2025
Kayne Anderson Rudnick Investment Management, LLC
7.20M
3.69%
-351.35K
-4.65%
Dec 31, 2025
T. Rowe Price Associates, Inc.
5.73M
2.94%
+2.23M
+63.80%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.27M
2.7%
-28.03K
-0.53%
Dec 31, 2025
Wellington Management Company, LLP
4.18M
2.14%
-2.01M
-32.42%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Indxx Medical Devices ETF
2.05%
Themes US R&D Champions ETF
1.96%
Invesco Bloomberg Pricing Power ETF
1.89%
State Street SPDR S&P Health Care Equipment ETF
1.85%
Invesco S&P 500 Equal Weight Health Care ETF
1.69%
Motley Fool Mid-Cap Growth ETF
1.59%
Congress SMid Growth ETF
1.42%
Invesco ESG NASDAQ Next Gen 100 ETF
1.19%
Pacer US Export Leaders ETF
0.95%
First Trust Health Care Alphadex Fund
0.89%
View more
First Trust Indxx Medical Devices ETF
Proportion2.05%
Themes US R&D Champions ETF
Proportion1.96%
Invesco Bloomberg Pricing Power ETF
Proportion1.89%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.85%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.69%
Motley Fool Mid-Cap Growth ETF
Proportion1.59%
Congress SMid Growth ETF
Proportion1.42%
Invesco ESG NASDAQ Next Gen 100 ETF
Proportion1.19%
Pacer US Export Leaders ETF
Proportion0.95%
First Trust Health Care Alphadex Fund
Proportion0.89%
Dividend
A total of
9.00M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jul 12, 2023
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2023 going ex on Jul 26, 2023
Jul 27, 2023
Aug 11, 2023
Jul 26, 2023
Dec 14, 2022
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2023 going ex on Jan 20, 2023
Jan 23, 2023
Feb 10, 2023
Jan 20, 2023
Jul 13, 2022
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2022 going ex on Jul 26, 2022
Jul 27, 2022
Aug 11, 2022
Jul 26, 2022
Dec 08, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2022 going ex on Jan 20, 2022
Jan 21, 2022
Feb 09, 2022
Jan 20, 2022
Jul 14, 2021
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2021 going ex on Jul 26, 2021
Jul 27, 2021
Aug 11, 2021
Jul 26, 2021
Jan 07, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2021 going ex on Jan 21, 2021
Jan 22, 2021
Feb 09, 2021
Jan 21, 2021
Jul 09, 2020
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 07, 2020 going ex on Jul 22, 2020
Jul 23, 2020
Aug 07, 2020
Jul 22, 2020
Jan 07, 2020
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2020 going ex on Jan 22, 2020
Jan 23, 2020
Feb 10, 2020
Jan 22, 2020
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Dec 07, 2023
Split
1→4
Date
Ex-dividend Date
Type
Ratio
Dec 07, 2023
Split
1→4
